New Domestic Partnerships Help DualityBio Become China ADC Bellwether
Executive Summary
China's Duality Biologics, founded in 2020, has developed two-thirds of its clinical-stage antibody-drug conjugates by combining antibodies acquired from domestic peers with its proprietary linker-payload platform.